Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 30 Jun 2026 for Vertex Pharmaceuticals INC / MA. Read the official filing
Filing timeline
BuySaleCarmen Bozic
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carmen Bozic: trading record in brief
This profile gathers the share dealings of Carmen Bozic in Vertex Pharmaceuticals INC / MA, where the filings describe the role as senior executive. In total, 46 filings cover trades dated from 28 May 2021 to 26 June 2026.
The open-market record consists of 21 sales worth €24.4M, with no purchase. No amount is published for 3 filings, which the totals therefore leave out. Besides market trades, the filings include 25 share grants. So far in 2026, the count stands at no purchases and 9 sales.
The newest entry dates from 30 June 2026: an open-market sale, in Vertex Pharmaceuticals INC / MA. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carmen Bozic
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
596 sharesCommon StockSEC:0000875320-26-000239:0
1,020 sharesCommon StockSEC:0000875320-26-000237:0
4,062 sharesCommon StockSEC:0000875320-26-000235:0
1,745 shares@ US$450.000.0005% mcap1.7% of flowCommon StockSEC:0000875320-26-000233:0
1,974 shares@ US$450.000.0007% mcap2.0% of flowCommon StockSEC:0000875320-26-000228:0
6,988 shares@ US$450.000.0024% mcap38.3% of flowCommon StockSEC:0000875320-26-000222:0
2,329 shares@ US$450.950.0008% mcap2.4% of flowCommon StockSEC:0000875320-26-000149:0
2,329 shares@ US$481.79100.0% of flowCommon StockSEC:0000875320-26-000140:0
2,329 shares@ US$480.3119.2% of flowCommon StockSEC:0000875320-26-000127:0
1,453 shares@ US$485.1112.1% of flowCommon StockSEC:0000875320-26-000110:0
5,375 shares0Common StockSEC:0000875320-26-000086:0
3,804 shares@ US$487.7631.7% of flowCommon StockSEC:0000875320-26-000066:0
2,145 shares@ US$468.4117.1% of flowCommon StockSEC:0000875320-26-000042:0
7,866 shares0Common StockSEC:0000875320-26-000016:0
4,962 shares@ US$479.615.9% of flowCommon StockSEC:0000875320-25-000129:0
3,310 shares@ US$483.284.0% of flowCommon StockSEC:0000875320-25-000109:0
1,912 shares@ US$463.462.2% of flowCommon StockSEC:0000875320-25-000087:0
5,546 shares0Common StockSEC:0000875320-25-000065:0
2,142 shares@ US$467.982.6% of flowCommon StockSEC:0000875320-25-000041:0
10,262 shares0Common StockSEC:0000875320-25-000016:0
2,280 shares@ US$476.752.6% of flowCommon StockSEC:0000875320-24-000202:0
2,280 shares@ US$488.462.7% of flowCommon StockSEC:0000875320-24-000189:0
2,280 shares@ US$487.342.7% of flowCommon StockSEC:0000875320-24-000183:0
2,280 shares@ US$471.722.6% of flowCommon StockSEC:0000875320-24-000181:0
2,280 shares@ US$478.002.6% of flowCommon StockSEC:0000875320-24-000176:0
25 of 46 declarations
